Healthcare Royalty Sales
McDermott Will & Emery offers a fully integrated, broadly based healthcare royalty sales and financing practice. This group employs the talents of our corporate, health law, intellectual property and tax lawyers. This cross-departmental group represents pharmaceutical and medical device companies and university medical centers in monetizing their intellectual property assets, as well as private equity and hedge funds in investing in these assets.
The following is a representative list of recent transactions:
- Sale of royalty interests by a German operating subsidiary of a publicly traded Canadian pharmaceutical company focused on human reproductive technologies
- Sale of royalty interests, mezzanine debt and preferred stock by a public Boston-based commercial-stage pharmaceutical company that is focused on the selling and marketing of products for cardiovascular, metabolic and respiratory diseases
- Sale of royalty interests by a public Princeton-based biopharmaceutical company discovering and developing innovative vaccines and targeted immunotherapeutics for the treatment of cancer, infectious and inflammatory diseases
- Sale of royalty interests and preferred stock by a private Princeton-based acute care cardiovascular pharmaceutical company
- Sale of revenue interests by a public New York-based biotechnology company developing therapies for spinal cord injury, multiple sclerosis and related nervous system disorders
- Sale of revenue interests and secured debt by a public San Diego-based medical technology company focused on developing, manufacturing and commercializing a new category of aesthetic injectable products for the dermatology and plastic surgery markets
- Sale of royalty stream by faculty members of a university medical center
- Sale of certain significant royalty rights by a group of U.S.-based research scientists
- Sale royalty interests from affiliates of a leading midwest university medical center relating to worldwide sales of an orally administered live human rotavirus vaccine
Contacts
- Jeffrey A. Jung
+1 312 984 6919
Send E-mail - John P. Tamisiea
+1 312 984 6957
Send E-mail
